Clinical trial
ACE Inhibition and Novel Cardiovascular Risk Factors
NCT00051389 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00051389 |
|---|---|
| Title | ACE Inhibition and Novel Cardiovascular Risk Factors |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases, Hypertension |
| Intervention type | Drug |
| Interventions | Fosinopril |
| Start date | Feb 1, 2002 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Jan 13, 2003 |
| Last update posted | Feb 18, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: